Ramelteon Tablet, Film Coated
Product Images NDC 59651-505

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ramelteon (NDC 59651-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (8 mg (30 Tablets Bottle))

Ramelteon Tablets 8 mg film-coated oral tablets packaging label by Aurobindo Pharma Limited. This prescription medication label indicates a package containing 30 tablets. The label features dosage and storage instructions, distributor information, and a barcode.*

FDA Label Image

Str (Ramelteon Str)

Chemical structure diagram of Ramelteon illustrating its molecular framework with labeled chemical groups and bonds, corresponding to the active ingredient in Ramelteon 8 mg film-coated tablets by Aurobindo Pharma Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.